Related Experiment Video

Updated: Aug 15, 2026

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4
09:29

Induction of Paralysis and Visual System Injury in Mice by T Cells Specific for Neuromyelitis Optica Autoantigen Aquaporin-4

Published on: August 21, 2017

Concomitant chronic inflammatory demyelinating polyneuropathy and myasthenia gravis following cytomegalovirus

Masahiro Mori1, Satoshi Kuwabara, Yuko Nemoto

  • 1Department of Neurology, Graduate School of Medicine, Chiba University, 1-8-1, Inohana, Chuo-ku, Chiba, 260-8670 Japan. morim@faculty.chiba-u.jp

Journal of the Neurological Sciences
|October 21, 2005
PubMed

Insights

This study reports the first case of simultaneous chronic inflammatory demyelinating polyneuropathy (CIDP) and myasthenia gravis (MG) after cytomegalovirus (CMV) infection. CMV may trigger both autoimmune disorders, though the link requires further investigation.

Area of Science:

  • Neurology
  • Immunology
  • Infectious Diseases

Background:

  • Chronic inflammatory demyelinating polyneuropathy (CIDP) and myasthenia gravis (MG) are distinct autoimmune disorders.
  • Cytomegalovirus (CMV) infection has been anecdotally associated with CIDP and MG individually.
  • The simultaneous occurrence of CIDP and MG is rare, and its association with preceding CMV infection is unprecedented.

Observation:

  • A patient developed both CIDP and MG concurrently.
  • The onset of these neurological conditions followed a cytomegalovirus infection.

Findings:

  • This case represents the first documented instance of concomitant CIDP and MG following CMV infection.
  • While the association could be coincidental, the findings suggest CMV infection as a potential trigger for both autoimmune neuropathies simultaneously.

Implications:

  • This case highlights a potential, albeit unproven, link between CMV infection and the development of multiple autoimmune neurological disorders.
  • Further research is warranted to explore the immunopathogenesis and confirm the causal relationship between CMV infection and the simultaneous onset of CIDP and MG.
  • Clinicians should consider CMV infection in the differential diagnosis for patients presenting with concurrent CIDP and MG.

Related Concept Videos

Cytomegalovirus Disease01:27

Cytomegalovirus Disease

Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Myasthenia Gravis: Overview and Treatment01:20

Myasthenia Gravis: Overview and Treatment

Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myasthenia Gravis: Diagnostic Tests01:15

Myasthenia Gravis: Diagnostic Tests

Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
Disorders of the Skeletal Muscle01:28

Disorders of the Skeletal Muscle

The clinical conditions affecting the skeletal muscle tissue are broadly categorized as musculoskeletal and neuromuscular disorders.
Musculoskeletal disorders
Musculoskeletal disorders involve injuries and conditions affecting the skeletal muscles and associated connective tissues. These disorders can arise from acute biomechanical stresses or chronic overuse and can occur across different age groups. Common injuries include sprains, fractures, and muscular strains, often resulting from...
Multiple Sclerosis l: Introduction01:19

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...